Bibliography
Ii, M., Matsunaga, N., Hazeki, K., Nakamura, K., Takashima, K., Seya, T., Hazeki, O., Kitazaki, T., & Iizawa, Y. (2006). A Novel Cyclohexene Derivative, Ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), Selectively Inhibits Toll-Like Receptor 4-Mediated Cytokine Production through Suppression of Intracellular Signaling. Molecular Pharmacology, 69(4), 1288â1295.
References
40
Referenced
315
10.1038/35099560
/ Nature (Lond) / Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 by Alexopoulou (2001)10.1002/1521-4141(200108)31:8<2448::AID-IMMU2448>3.0.CO;2-N
/ Eur J Immunol / The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol by Byrd-Leifer (2001)10.1126/science.7701344
/ Science (Wash DC) / E5531, a pure endotoxin antagonist of high potency by Christ (1995)10.1074/jbc.M009164200
/ J Biol Chem / Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. Transfer from CD14 to TLR4 and MD-2 by da Silva Correia (2001)10.1016/j.febslet.2005.04.024
/ FEBS Lett / Adaptor usage and Toll-like receptor signaling specificity by Dunne (2005)10.1016/S0140-6736(88)90185-7
/ Lancet / Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis by Eastgate (1988){'key': '10.1124/mol.105.019695_bib7', 'first-page': '149', 'article-title': 'Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14', 'volume': '8', 'author': 'Ellingsen', 'year': '2002', 'journal-title': 'Med Sci Monit'}
/ Med Sci Monit / Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14 by Ellingsen (2002)10.1172/JCI115748
/ J Clin Investig / Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock but fails to alter host responses to sublethal endotoxemia by Fischer (1992)10.1084/jem.20031023
/ J Exp Med / LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the toll adapters TRAM and TRIF by Fitzgerald (2003)10.4049/jimmunol.174.10.6416
/ J Immunol / A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease by Fort (2005)10.1016/S0898-6568(00)00149-2
/ Cell Signal / LPS induction of gene expression in human monocytes by Guha (2001){'key': '10.1124/mol.105.019695_bib12', 'first-page': '469', 'article-title': 'Nitric oxide and superoxide in inflammation and immune regulation', 'volume': '54', 'author': 'Guzik', 'year': '2003', 'journal-title': 'J Physiol Pharmacol'}
/ J Physiol Pharmacol / Nitric oxide and superoxide in inflammation and immune regulation by Guzik (2003)10.1111/j.1365-2567.2005.02143.x
/ Immunology / The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games by Hehlgans (2005)10.1038/35047123
/ Nature (Lond) / A Toll-like receptor recognizes bacterial DNA by Hemmi (2000)10.1111/j.1365-2249.2005.02801.x
/ Clin Exp Immunol / Mammalian Toll-like receptors: to immunity and beyond by Hopkins (2005)10.1056/NEJMoa012673
/ N Engl J Med / Toll-like receptor 4 polymorphisms and atherogenesis by Kiechl (2002)10.1038/sj.ijo.0802498
/ Int J Obes Relat Metab Disord / Macrophages, inflammation and atherosclerosis by Linton (2003)10.1001/archinte.162.9.1028
/ Arch Intern Med / Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock by Lorenz (2002)10.1007/BF02358624
/ J Gastroenterol / Alterations of the mucosal immune system in inflammatory bowel disease by MacDermott (1996)10.1006/abio.1993.1449
/ Anal Biochem / A fluorometric assay for the measurement of nitrite in biological samples by Misko (1993)10.1124/jpet.102.044487
/ J Pharmacol Exp Ther / Inhibition of endotoxin response by E5564, a novel Toll-like receptor 4-directed endotoxin antagonist by Mullarkey (2003)10.1034/j.1398-9995.2001.056002103.x
/ Allergy / The Toll receptor family by Muzio (2000)10.1038/ni809
/ Nat Immunol / Essential role of MD-2 in LPS responsiveness and TLR4 distribution by Nagai (2002){'key': '10.1124/mol.105.019695_bib24', 'first-page': '369', 'article-title': 'Maintenance of dynamic microvascular function and structure in a rat model of endotoxic shock by blockade of the interleukin-1 receptor', 'volume': '3', 'author': 'Norman', 'year': '1995', 'journal-title': 'Shock'}
/ Shock / Maintenance of dynamic microvascular function and structure in a rat model of endotoxic shock by blockade of the interleukin-1 receptor by Norman (1995)10.1016/S1471-4892(03)00080-8
/ Curr Opin Pharmacol / Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases by O'Neill (2003)10.1038/ni886
/ Nat Immunol / TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction by Oshiumi (2003)10.1074/jbc.M305820200
/ J Biol Chem / TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-β by Oshiumi (2003){'key': '10.1124/mol.105.019695_bib28', 'first-page': '493', 'article-title': 'Nitric oxide. A key mediator in sepsis and endotoxaemia?', 'volume': '48', 'author': 'Parratt', 'year': '1997', 'journal-title': 'J Physiol Pharmacol'}
/ J Physiol Pharmacol / Nitric oxide. A key mediator in sepsis and endotoxaemia? by Parratt (1997)10.1002/1097-0029(20000801)50:3<229::AID-JEMT6>3.0.CO;2-H
/ Microsc Res Tech / Anti-TNF therapies in rheumatoid arthritis, Crohn's disease, sepsis and myelodysplastic syndromes by Raza (2000)10.1152/physrev.00034.2003
/ Physiol Rev / Nitric oxide in health and disease of the respiratory system by Ricciardolo (2004)10.1111/j.0105-2896.2005.00239.x
/ Immunol Rev / Toll-like receptors, endogenous ligands and systemic autoimmune disease by Rifkin (2005)10.1177/09680519020080060601
/ J Endotoxin Res / Antagonism of in vivo and ex vivo response to endotoxin by E5564, a synthetic lipid A analogue by Rossignol (2002)10.1164/ajrccm.154.4.8887608
/ Am J Respir Crit Care Med / Expression of interleukin-1 beta (IL-1beta) and interleukin-1 receptor antagonist (IL-1ra) on asthmatic bronchial epithelium by Sausa (1996)10.1016/S0305-4179(02)00187-0
/ Burns / Macrophages and post-burn immune dysfunction by Schwacha (2003)10.1084/jem.189.11.1777
/ J Exp Med / MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4 by Shimazu (1999)10.1016/S1074-7613(00)80119-3
/ Immunity / Differential roles of TLR2 and TLR4 in recognition of Gram-negative and gram-positive bacterial cell wall components by Takeuchi (1999)10.1046/j.1432-1327.2000.01222.x
/ Eur J Biochem / Rough and smooth forms of fluorescein-labelled bacterial endotoxin exhibit CD14/LBP dependent and independent binding that is influenced by endotoxin concentration by Triantafilou (2000)10.1126/science.1698311
/ Science (Wash DC) / CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein by Wright (1990)10.1038/ni986
/ Nat Immunol / TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway by Yamamoto (2003)10.4049/jimmunol.169.12.6668
/ J Immunol / A novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling by Yamamoto (2002)
Dates
Type | When |
---|---|
Created | 19 years, 8 months ago (Dec. 22, 2005, 9:13 p.m.) |
Deposited | 6 months ago (Feb. 20, 2025, 4:06 a.m.) |
Indexed | 2 days, 16 hours ago (Aug. 23, 2025, 1:01 a.m.) |
Issued | 19 years, 4 months ago (April 1, 2006) |
Published | 19 years, 4 months ago (April 1, 2006) |
Published Print | 19 years, 4 months ago (April 1, 2006) |
@article{Ii_2006, title={A Novel Cyclohexene Derivative, Ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), Selectively Inhibits Toll-Like Receptor 4-Mediated Cytokine Production through Suppression of Intracellular Signaling}, volume={69}, ISSN={0026-895X}, url={http://dx.doi.org/10.1124/mol.105.019695}, DOI={10.1124/mol.105.019695}, number={4}, journal={Molecular Pharmacology}, publisher={Elsevier BV}, author={Ii, Masayuki and Matsunaga, Naoko and Hazeki, Kaoru and Nakamura, Kazuyo and Takashima, Katsunori and Seya, Tsukasa and Hazeki, Osamu and Kitazaki, Tomoyuki and Iizawa, Yuji}, year={2006}, month=apr, pages={1288–1295} }